Saudi Arabia Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Saudi Arabia Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Saudi Arabia respiratory devices market is expected to register a CAGR of 5.5% during the forecast period.

Respiratory devices, such as ventilators, nebulizers, CPAP, BiPAP, and oxygen concentrators are witnessed the highest demand, as they are widely being used for COVID-19 patients. The article titled "Bed Surge Capacity in Saudi Hospitals During the COVID-19 Pandemic" published in Cambridge University Press Public Health Emergency Collection in April 2021 stated that the rate of hospital admission of COVID-19 patients ranged from 11% to 62% over the period from April to September 2020. The Saudi authority has obliged mask-wearing in public places to reduce the risk of viral transmission in the community. It stated that there was a high demand for ICU beds with ventilators for the management of COVID-19-positive patients. The ministry of health (MOH) supplied an additional 3728 hospital beds accompanied by mechanical ventilators to hospitals created to face the COVID-19 outbreak. In the ICU context, the number of extracorporeal membrane oxygenation machines within Saudi Arabia was 24 machines. This indicated the immense need for respiratory devices, such as ventilators in the country impacted by COVID-19. Hence, it is observed that the market studied is positively impacted by the covid pandemic.

In addition, the increasing prevalence of respiratory disorders, rising government initiatives, and large patient populations are actively affecting the growth of the studied market.

The article titled "The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children" published in the Annals of Thoracic Medicine in January 2021stated that asthma is one of the most prevalent chronic illnesses in Saudi Arabia, and local reports suggested that the prevalence of asthma is increasing. Based on studies undertaken over the past three decades, it was claimed that the overall prevalence of asthma in Saudi Arabian children ranges from 8% to 25%. Also, an article titled "A Saudi Arabian Public Health Perspective of Tuberculosis" published in International Journal of Environmental Research and Public Health in September 2021 stated that M. tuberculosis is endemic in the Middle East with incidence of 14 per 100,000 people in Kingdom of Saudi Arabia. The high burden of respiratory diseases like asthma and tuberculosis is projected to boost the demand for respiratory devices for the management of diseases and ultimately augment the market growth.

Furthermore, the product approvals, launches, partnerships and acquisitons by the key market players are projected to augment the market growth in the country. For instance, in July 2020, Sedana Medical AB received market approval for its medical device AnaConDa in Saudi Arabia and the company signed distribution agreements for sales in the Middle East with Techno Orbits in Saudi Arabia. The anaesthetic conserving device AnaConDa is a device that delivers a safe sedative dose to a patient using existing critical care ventilators, common syringe pumps and gas monitors. Also, in March 2021, Philips partnered for three-year with the Middle East Healthcare Company (MEAHCO) to launch state-of-the-art sleep disorder management services in Saudi Arabia through Saudi German Health Group. The partnership is intended to offer innovative solutions to patients suffering from severe disorders such as Obstructive Sleep Apnea (OSA). Such approvals and partnerships by key market players are expected to increase the utility of respiratory devices in the country and augment the market growth.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period. however, the high cost of devices is likely to impede the market growth.

Key Market TrendsInhalers Segment is Expected to Witness Growth Over the Forecast Period

An inhaler is a portable device for administering a drug while breathing used for relieving asthma and other bronchial or nasal congestion.

The COVID-19 outbreak increased awareness about respiratory disease management and the demand for many respiratory devices has grown ever since.

The article titled "The Saudi Initiative for Asthma - 2021 Update: Guidelines for the diagnosis and management of asthma in adults and children" published in the Annals of Thoracic Medicine in January 2021stated that a study conducted by the Saudi Thoracic Society investigated the prevalence of asthma and its associated symptoms in 16–18-year-old adolescents attending high schools in Riyadh. This study used the International Study of Asthma and Allergies in Children (ISAAC) questionnaire tool. Out of 3073 students, the prevalence of lifetime wheeze and physician-diagnosed asthma was 25.3% and 19.6% respectively. The prevalence of rhinitis symptoms in students with lifetime and wheeze, physician-diagnosed asthma was 61.1% and 59.9% respectively. By using the ISAAC questionnaire method, another study conducted among 5188 primary school children in Madinah showed that the prevalence of asthma was 23.6%, while 41.7% had symptoms suggestive of at least one allergic disorder. The high prevalence of asthma in the country is projected to boost the demand for inhalers and augment the segments growth during the forecast period of study.

Competitive Landscape

The saudi arabia respiratory devices market is consolidated in nature due to the presence of a few companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known. Some key market players are Dragerwerk AG, Fisher & Paykel Healthcare Limited, General Electric company (GE Healthcare), GSK plc, Invacare Corporation, Koninklijke Philips N.V, Medtronic PLC, and ResMed Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.